FDA Nears Decision On Moderna mRNA Flu Shot After February Reversal
2h
1
The U.S. Food and Drug Administration must decide by Wednesday, August 5, 2026, whether to approve Moderna's experimental mRNA seasonal flu vaccine, a ruling that could reshape mRNA investment and vaccine markets. NPR
